I had not thought about this, thanks for pointing it out. After the CC I was in agreement that we should try and get all 75 in the M2M trial before releasing data, but I now think the sooner the better. If we can show the results ASAP, the desire to get into Leronlimab trials will be stronger than any other trial for any other drug or combo. We have to get out front and show that these other drugs really do not show much promise and are wasting time and resources to get to a real treatment ASAP.